Home | By sponsor

INSTITUTO FINLAY DE VACUNAS

Trials shown by sponsor

Public title Date of Registration State
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain 29/12/2016 Registered
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. 28/04/2017 Registered
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study 22/05/2020 Registered
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 22/05/2020 Registered
Clinical Trial with the Outer Membrane Vesicles (OMV) Bivalent AW135 Anti meningocóccal Vacccine Candidate 2013-06-19 Registered
Study of the tetanus vaccine vax-TET®-5 2013-06-10 Registered
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba. 2008-09-19 Registered
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique. 2008-09-12 Registered
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain. 2008-09-12 Registered
Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants. 2008-07-29 Registered
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers. 2008-07-29 Registered
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age. 2008-07-29 Registered
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET. 2008-07-29 Registered
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine. 2008-07-29 Registered
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect) 13/10/2017 Registered
SOBERANA 01 13/08/2020 Registered
Randomized double blind controlled, phase I clinical trial, to assess safety, reactogenicity and immunogenicity of the 638 vaccine candidate, in healthy female and male children and adolescents aged from 5 to 17 years old from Cienfuegos Province, Cuba. 11/10/2013 Registered
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . 06/11/2014 Registered
Study of the meningococcal ACW135 polysaccharide vaccine 04/12/2015 Registered